These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7695327)

  • 21. Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
    Hammerschlag MR; Reznik T; Roblin PM; Ramirez J; Summersgill J; Bukofzer S
    J Antimicrob Chemother; 2003 Apr; 51(4):1025-8. PubMed ID: 12654764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment Effectiveness of Azithromycin and Doxycycline in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study (FemCure).
    Dukers-Muijrers NHTM; Wolffs PFG; De Vries H; Götz HM; Heijman T; Bruisten S; Eppings L; Hogewoning A; Steenbakkers M; Lucchesi M; Schim van der Loeff MF; Hoebe CJPA
    Clin Infect Dis; 2019 Nov; 69(11):1946-1954. PubMed ID: 30689759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone.
    Malinverni R; Kuo CC; Campbell LA; Grayston JT
    J Infect Dis; 1995 Aug; 172(2):593-4. PubMed ID: 7622914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women.
    Lea AP; Lamb HM
    Pharmacoeconomics; 1997 Nov; 12(5):596-611. PubMed ID: 10174326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of therapy with antibiotics on lipid metabolism and antioxidant reserve of patients with ischemic heart disease during Chlamydia pneumoniae infection].
    Klochkov VA; Dovgalevskiĭ PIa; Umetskiĭ KS; Chalyk NE; Ansimova OM; Zigangirova NA; Petiaev I
    Kardiologiia; 2005; 45(12):58-61. PubMed ID: 16353050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of Chlamydia pneumoniae infection in cyclosporin A-induced post-transplant gingival overgrowth tissue and evidence for the possibility of persistent infection despite short-term treatment with azithromycin.
    Worm HC; Wirnsberger GH; Mauric A; Holzer H
    Nephrol Dial Transplant; 2004 Jul; 19(7):1890-4. PubMed ID: 15128877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doxycycline suppresses Chlamydia pneumoniae induced interferon-gamma responses in peripheral blood mononuclear cells in children with allergic asthma.
    Smith-Norowitz TA; Weaver D; Norowitz YM; Hammerschlag MR; Joks R; Durkin HG; Kohlhoff S
    J Infect Chemother; 2018 Jun; 24(6):470-475. PubMed ID: 29615379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and therapy of Chlamydia pneumoniae and trachomatis].
    Freidank H
    Internist (Berl); 1997 Oct; 38(10):995-6. PubMed ID: 9432510
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis.
    Skerk V; Krhen I; Lisić M; Begovac J; Roglić S; Skerk V; Sternak SL; Banaszak A; Strugar-Suica J; Vuković J
    Int J Antimicrob Agents; 2004 Aug; 24(2):188-91. PubMed ID: 15288321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibilities of Chlamydia pneumoniae isolates from German patients and synergistic activity of antibiotic combinations.
    Freidank HM; Losch P; Vögele H; Wiedmann-Al-Ahmad M
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1808-10. PubMed ID: 10390251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.
    Agacfidan A; Moncada J; Schachter J
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1746-8. PubMed ID: 8239579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pneumopathies caused by Chlamydia pneumoniae].
    Bruaire JP; Ducroix JP; Eb F; Smail A; Cohen G; Orfila J; Baillet J
    Presse Med; 1992 Jun; 21(23):1064-9. PubMed ID: 1326110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of Chlamydia pneumoniae to azithromycin and doxycycline: methodological aspects on the determination of minimal inhibitory and minimal bactericidal concentrations.
    Nyström-Rosander C; Hultén K; Gustavsson I; Cars O; Engstrand L; Hjelm E
    Scand J Infect Dis; 1997; 29(5):513-6. PubMed ID: 9435043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis.
    Roblin PM; Hammerschlag MR
    Int J Antimicrob Agents; 2000 Sep; 16(1):61-3. PubMed ID: 11185415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of azithromycin and doxycycline treatment for rectal chlamydial infection: a retrospective cohort study in South Australia.
    Li B; Hocking JS; Bi P; Bell C; Fairley CK
    Intern Med J; 2018 Mar; 48(3):259-264. PubMed ID: 28967178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study.
    Stamm WE; Hicks CB; Martin DH; Leone P; Hook EW; Cooper RH; Cohen MS; Batteiger BE; Workowski K; McCormack WM
    JAMA; 1995 Aug; 274(7):545-9. PubMed ID: 7629982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men - a double-blind randomised controlled trial protocol.
    Lau A; Kong F; Fairley CK; Donovan B; Chen M; Bradshaw C; Boyd M; Amin J; Timms P; Tabrizi S; Regan DG; Lewis DA; McNulty A; Hocking JS
    BMC Infect Dis; 2017 Jan; 17(1):35. PubMed ID: 28061753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia.
    Roblin PM; Montalban G; Hammerschlag MR
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1588-9. PubMed ID: 7979292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model.
    Kutlin A; Roblin PM; Hammerschlag MR
    J Antimicrob Chemother; 2002 May; 49(5):763-7. PubMed ID: 12003969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preliminary study on Chlamydia pneumoniae pneumonia].
    Su X; Li G; Hai Z; Yang H
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):76-8. PubMed ID: 10681804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.